pyrazinamide has been researched along with Anemia, Macrocytic in 1 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Anemia, Macrocytic: Anemia characterized by larger than normal erythrocytes, increased mean corpuscular volume (MCV) and increased mean corpuscular hemoglobin (MCH).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muranda, M | 1 |
| Del Solar, JA | 1 |
| Jorquera, C | 1 |
| Saavedra, L | 1 |
| Pemjean, I | 1 |
1 other study available for pyrazinamide and Anemia, Macrocytic
| Article | Year |
|---|---|
[Megaloblastic anemia caused by pyrazinamide].
Topics: Adult; Anemia, Macrocytic; Female; Folic Acid; Humans; Pyrazinamide; Tuberculosis, Pulmonary | 1973 |